Sa1887 PROACTIVE DRUG MONITORING IS ASSOCIATED WITH HIGHER PERSISTENCE TO INFLIXIMAB AND ADALIMUMAB TREATMENT AND LOWER HEALTHCARE UTILIZATION COMPARED TO REACTIVE AND CLINICAL MONITORING

Authors

Mazen Tolaymat MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2020

Volume

158

Issue

6

Published In/Presented At

10.1016/S0016-5085(20)31846-1

Disciplines

Medicine and Health Sciences | Pediatrics

Department(s)

Department of Pediatrics

Document Type

Article